CINECA IRIS Institutional Research Information System

VIRDIS, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.198
AS - Asia 10.556
EU - Europa 6.599
SA - Sud America 1.716
AF - Africa 363
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.457
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.614
SG - Singapore 3.232
CN - Cina 2.942
IT - Italia 1.906
HK - Hong Kong 1.897
BR - Brasile 1.444
SE - Svezia 921
VN - Vietnam 897
DE - Germania 806
BG - Bulgaria 659
TR - Turchia 488
CA - Canada 452
GB - Regno Unito 431
FI - Finlandia 397
RU - Federazione Russa 370
FR - Francia 367
UA - Ucraina 283
KR - Corea 230
IN - India 211
JP - Giappone 138
CI - Costa d'Avorio 137
CH - Svizzera 102
AR - Argentina 93
BD - Bangladesh 86
IQ - Iraq 67
NL - Olanda 61
MX - Messico 60
ZA - Sudafrica 59
PK - Pakistan 55
ID - Indonesia 54
BE - Belgio 48
ES - Italia 48
EC - Ecuador 41
PL - Polonia 39
AT - Austria 37
UZ - Uzbekistan 37
CO - Colombia 36
SA - Arabia Saudita 33
PY - Paraguay 30
VE - Venezuela 29
SN - Senegal 28
MA - Marocco 22
TN - Tunisia 22
PH - Filippine 21
GR - Grecia 19
IE - Irlanda 18
CL - Cile 17
DZ - Algeria 17
BJ - Benin 16
JO - Giordania 15
NG - Nigeria 15
IL - Israele 14
JM - Giamaica 14
KE - Kenya 14
MY - Malesia 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
AU - Australia 12
CR - Costa Rica 12
EG - Egitto 12
NP - Nepal 12
TT - Trinidad e Tobago 12
TH - Thailandia 11
KG - Kirghizistan 10
OM - Oman 10
BH - Bahrain 9
RS - Serbia 9
AZ - Azerbaigian 8
DK - Danimarca 8
KZ - Kazakistan 8
RO - Romania 8
LB - Libano 7
LT - Lituania 7
AL - Albania 6
CZ - Repubblica Ceca 6
HN - Honduras 6
HR - Croazia 6
NI - Nicaragua 6
PT - Portogallo 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EU - Europa 5
GT - Guatemala 5
HU - Ungheria 5
PE - Perù 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
AM - Armenia 3
BN - Brunei Darussalam 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
SV - El Salvador 3
Totale 41.402
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.389
Ashburn 2.097
Singapore 1.892
Hong Kong 1.864
Houston 1.743
Fairfield 1.713
Ann Arbor 1.687
San Jose 1.121
Chandler 1.088
Santa Clara 992
Dallas 813
Seattle 741
Sofia 657
Shanghai 643
Beijing 622
Wilmington 590
Cambridge 570
New York 493
Serra 478
Milan 379
Ottawa 366
Jacksonville 344
Boardman 340
Princeton 291
Hefei 279
Izmir 277
Lawrence 271
Los Angeles 255
Medford 244
Lauterbourg 240
Nanjing 227
Seoul 223
Ho Chi Minh City 215
Council Bluffs 197
Munich 193
Des Moines 173
Hanoi 154
Istanbul 151
Abidjan 137
Helsinki 128
Frankfurt am Main 124
Redondo Beach 123
Tokyo 119
Florence 114
Pisa 114
Buffalo 112
Nanchang 108
São Paulo 107
San Diego 101
Dong Ket 98
Lancaster 95
Dearborn 89
Bern 84
Boulder 82
The Dalles 66
Columbus 64
London 63
Falls Church 59
Kunming 59
Ogden 54
Chicago 52
Rome 50
Shenyang 50
Jüchen 47
Rio de Janeiro 47
Brussels 44
Jinan 44
Redwood City 44
Tianjin 43
Belo Horizonte 39
Changsha 39
Turku 39
Amsterdam 35
Hebei 35
Nuremberg 35
Tashkent 35
Da Nang 34
Washington 34
Brasília 31
Fuzhou 31
Pune 30
Atlanta 28
Dakar 28
Phoenix 28
Norwalk 27
Saint Petersburg 27
San Francisco 27
Vienna 27
Warsaw 27
Baghdad 26
Salt Lake City 26
Hangzhou 25
Jakarta 25
Brooklyn 24
Auburn Hills 23
Jiaxing 23
Toronto 23
Curitiba 22
Mumbai 22
Nürnberg 22
Totale 30.430
Salva come PNG Salva come JPEG
Nome #
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 467
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 327
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 308
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 272
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 234
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 229
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 225
Cigarette Smoking and Hypertension 219
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 212
Device-based therapies for resistant hypertension. 212
Aging and hypertension. What about the endothelium? 210
Obesity in the childhood: a link to adult hypertension 209
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 204
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 204
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 204
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 201
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy 198
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 198
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 197
Circulating mitochondrial DNA signature in cardiometabolic patients 193
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 191
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 191
Spironolactone improves angiotensin-induced vascular changes and oxidative stress 190
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 190
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 190
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 188
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 187
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma 185
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 184
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 183
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 182
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 180
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 179
Donepezil improves vascular function in a mouse model of Alzheimer's disease 179
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 178
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 177
Adenosine causes angiotensin II release in human forearm arterioles. 177
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. 177
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 177
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 176
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 176
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 176
Vascular inflammation: a role in vascular disease in hypertension? 175
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats 174
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients 174
Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure 174
Menopause is associated with endothelial dysfunction in women 173
Hypertension causes premature aging of endothelial function in humans 173
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 172
Hypertension and cardiometabolic risk factors. 172
Forearm vasodilation to acetylcholine is increased by potassium in essential hypertensive patients 171
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 171
Microvascular Endothelial Dysfunction in Patients with Obesity 171
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension 171
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development? 170
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 169
Endothelial function assessment in complicated hypertension 168
Ventricular and vascular stiffening in aging and hypertension 167
Vascular reactivity in patients with undifferentiated connective tissue diseases 166
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 166
ROLE OF NAD(P)H OXIDASE ON VASCULAR ALTERATIONS IN ANGIOTENSIN II-INFUSED MICE 165
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy 165
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. 165
Endothelial function in hypertension. Evidences in humans. 164
Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. 164
Microvascular endothelial dysfunction in obesity and hypertension. 163
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. 163
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction 162
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 162
Endothelial function in hypertension 162
Systemic inflammation and endothelial dysfunction in patients with Hashimoto’s thyroiditis and subclinical hypothyroidism 161
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 161
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 160
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 160
Endothelial dysfunction as a target for prevention of cardiovascular disease 160
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 159
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 159
Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. 158
Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. 158
Effects of wine and grape polyphenols on blood pressure, endothelial function and sympathetic nervous system activity in treated hypertensive subjects 158
Microvascular endothelial dysfunction in human obesity: role of TNF-α 158
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 157
The renal resistive index is associated with microvascular remodeling in patients with severe obesity 156
Endothelium dependent forearm vasodilation is reduced in normotensives with familial history of hypertension. 156
Blood pressure and vascular alterations with growth in childhood. 156
C-Reactive Protein and Hypertension: is there a causal relationship? 155
Human endothelial dysfunction: EDCFs 155
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women 154
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II 154
Central blood pressure, arterial stiffness, and wave reflection: New targets of treatment in essential hypertension 153
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension 152
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 152
The eye and the heart 152
Hypertension in the elderly: an evidence-based review. 151
Aging and endothelial function in normotensive subjects and essential hypertensive patients 150
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy 150
Age- and Sex-Specific Reference Values for Media/Lumen Ratio in Small Arteries and Relationship With Risk Factors 150
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy 150
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis 149
Totale 18.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.920 55 181 55 176 532 401 100 184 131 143 142 820
2022/20233.112 384 324 200 276 337 437 14 264 585 31 220 40
2023/20242.317 229 227 277 140 339 467 104 58 52 47 87 290
2024/20258.794 60 344 142 442 690 918 770 532 875 1.217 1.055 1.749
2025/20269.729 559 1.209 1.193 923 1.044 935 1.381 485 566 826 328 280
2026/202791 91 0 0 0 0 0 0 0 0 0 0 0
Totale 42.001